BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11137241)

  • 1. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
    Frangione-Beebe M; Albrecht B; Dakappagari N; Rose RT; Brooks CL; Schwendeman SP; Lairmore MD; Kaumaya PT
    Vaccine; 2000 Dec; 19(9-10):1068-81. PubMed ID: 11137241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
    Frangione-Beebe M; Rose RT; Kaumaya PT; Schwendeman SP
    J Microencapsul; 2001; 18(5):663-77. PubMed ID: 11508771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
    Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
    Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
    J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
    Lairmore MD; Rudolph DL; Roberts BD; Dezzutti CS; Lal RB
    Cancer Lett; 1992 Sep; 66(1):11-20. PubMed ID: 1360328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.
    Sundaram R; Lynch MP; Rawale SV; Sun Y; Kazanji M; Kaumaya PT
    J Biol Chem; 2004 Jun; 279(23):24141-51. PubMed ID: 15060075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural properties of chimeric peptides containing a T-cell epitope linked to a fusion peptide and their importance for in vivo induction of cytotoxic T-cell responses.
    Lelièvre D; Hsu SC; Daubos P; Favard C; Vigny P; Trudelle Y; Steward MW; Delmas A
    Eur J Biochem; 1997 Nov; 249(3):895-904. PubMed ID: 9395341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system.
    Arp J; Ford CM; Palker TJ; King EE; Dekaban GA
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():211-22. PubMed ID: 8429302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
    Kaumaya PT; Conrad SF; DiGeorge AM; Lairmore MD
    Leukemia; 1995 Oct; 9 Suppl 1():S133-8. PubMed ID: 7475306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features of a chimeric peptide inducing cytotoxic T lymphocyte responses in saline.
    Delmotte C; Le Guern E; Trudelle Y; Delmas A
    Eur J Biochem; 1999 Oct; 265(1):336-45. PubMed ID: 10491190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.